Typhoid fever
- PMID: 25458731
- PMCID: PMC11567078
- DOI: 10.1016/S0140-6736(13)62708-7
Typhoid fever
Abstract
Control of typhoid fever relies on clinical information, diagnosis, and an understanding for the epidemiology of the disease. Despite the breadth of work done so far, much is not known about the biology of this human-adapted bacterial pathogen and the complexity of the disease in endemic areas, especially those in Africa. The main barriers to control are vaccines that are not immunogenic in very young children and the development of multidrug resistance, which threatens efficacy of antimicrobial chemotherapy. Clinicians, microbiologists, and epidemiologists worldwide need to be familiar with shifting trends in enteric fever. This knowledge is crucial, both to control the disease and to manage cases. Additionally, salmonella serovars that cause human infection can change over time and location. In areas of Asia, multidrug-resistant Salmonella enterica serovar Typhi (S Typhi) has been the main cause of enteric fever, but now S Typhi is being displaced by infections with drug-resistant S enterica serovar Paratyphi A. New conjugate vaccines are imminent and new treatments have been promised, but the engagement of local medical and public health institutions in endemic areas is needed to allow surveillance and to implement control measures.
Copyright © 2015 Elsevier Ltd. All rights reserved.
Conflict of interest statement
Declaration of interests
KHK is a permanent employee of the National Institute for Communicable Diseases, South Africa. MLM is a permanent employee of the US Government (Department of Health and Human Services, Centers for Disease Control and Prevention). The findings and conclusions in this manuscript are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention. RSH is permanently employed by the Technical University of Denmark, National Food Institute. JW is the Chief Scientific Officer and Director for Discuva, an antibiotic discovery company. RLO is currently an employee of SanofiPasteur, which is a producer of typhoid vaccine. He was formerly an employee of the International Vaccine Institute, Seoul, Korea and independent at the time of writing
Figures


References
-
- Khan KH. Recent trends in typhoid research—A Review. Int J Biosci 2012; 2: 110–20.
-
- Parry CM, Wijedoru L, Arjyal A, Baker S. The utility of diagnostic tests for enteric fever in endemic locations. Expert Rev Anti Infect Ther 2011; 9: 711–25. - PubMed
-
- Wain J, Hosoglu S. The laboratory diagnosis of enteric fever. J Infect Dev Ctries 2008; 2: 421–25. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical